Texas Heart Institute Home
Continuing Medical Education
 
CME Home
 

To participate in this event:
1. Read CME information.
2. View course materials.
3. Complete assessment. 
4. Obtain CME credit.

 
Emerging Trends - Online Symposium

Emerging Trends in the Management of
Arrhythmias and Pump Failure in Patients with
Advanced Heart Failure

Date of Online Release: March 12, 2009
Date of Original Presentation: February 6-7, 2009
Credits: 4 AMA PRA Category 1 Credits™

To view presentations, see Course Materials below.

CME Information - Overview


Nearly six million Americans have congestive heart failure with 550,000 new cases diagnosed each year. The patients are at increased risk of life-threatening cardiac arrhythmias. About half of these patients die within five years after receiving a diagnosis of severe heart failure. Recent advances in diagnosis and treatment of cardiac arrhythmias and in management of heart failure have significantly enhanced our ability to help patients with cardiac arrhythmias and heart failure, improving their quality of life and prolonging their life expectancy.

Educational Objectives
The intended result of this activity is increased knowledge. At the conclusion of this symposium, participants should be able to--

  • Summarize recent scientific advances related to management of complex cardiac arrhythmias and advanced heart failure.
  • Cite the indications and appropriate use of interventional therapies and device therapies for complex cardiac arrhythmias and heart failure.
  • Discuss the efficacies and potential risks associated with these advanced therapies for patients with complex cardiac arrhythmias and heart failure.

Target Audience
The intended audience for this continuing medical education activity includes cardiologists,  internists, and electrophysiologists.

Method of Instruction / Participation
This online enduring material comprises slide sets with text and audio derived from a live symposium with post activity assessment and evaluation.

Evaluation / Feedback
We value your comments; please send your suggestions and comments to the Office of Continuing Medical Education at Texas Heart Institute, cme@heart.thi.tmc.edu.

Program Directors

Jie Cheng, MD, PhD
Reynolds Delgado III, MD
Texas Heart Institute
Houston, Texas


Acknowledgement of Support

We acknowledge the following for their support of the live event from which this activity was derived: Boston Scientific Corporation and Medtronic, Inc. No grants were received for the production of these online enduring materials
.

Accreditation / Credit Designation

Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Texas Heart Institute designates this educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Estimated Study Time
The estimated time to complete this activity, including review of the materials and completion of the course assessment is 4 hours.

Repurposing Statement
If you previously completed and received credit for the live CME-sponsored symposium entitled, Emerging Trends in the Management of Arrhythmias and Pump Failure in Patients with Advanced Herat Failure on February 6-7, 2009, please note that you will not receive credit for completing this activity. Participants who take part in an identical activity, even in order to validate learning or to clarify specific topics, cannot claim, nor will the Texas Heart Institute award, duplicate credit for the activity.

Term of Approval
March 12, 2009 through March 12, 2012. Continuation of CME credit from March 12, 2012 depends upon a thorough review of the content for currency and accuracy.

Peer Review
In March 2009, this continuing medical education activity was reviewed for currency and accuracy of content by Patrick J. Hogan, MD, FACC, Director Learning Resource Center and Co-Chairman, Medical Education Committee, Texas Heart Institute, Houston, TX.

Disclosure of Relationships
It is the intent of the Texas Heart Institute to ensure that its educational mission and its continuing medical activities in particular, should not be influenced by the special interests of individuals associated with its program.

Faculty Disclosure
In accordance with the guidelines of the Accreditation Council for Continuing Medical Education, faculty members have disclosed their relationships, either with one or more of the manufacturers of commercial products discussed, or with one or more of the corporate organizations offering educational grants for the live continuing medical education activity.

Richard Abben, MD does not have any disclosures relevant to this program.

William Bailey, MD does not have any discloses relevant to this program.

Roberta Bogaev, MD discloses the following, relevant to this program: Grant/Research Support—Thoratec Corporation and XDx, Inc.; Consultant Honoraria—Thoratec Corporation, Boston Scientific Corporation, and XDx, Inc; Speakers Bureau—Thoratec Corporation.

Paris Branford, MD does not have any discloses relevant to this program.

Jie Cheng, MD, PhD (Program Director) discloses the following, relevant to this program: Grant/Research Support—St. Jude Medical, Inc., Medtronic, Inc., and Boston Scientific Corporation; Consultant/Honoraria—St. Jude Medical, Inc.

Reynolds Delgado III, MD (Program Co-Director) discloses the following, relevant to this program: Consultant/Honoraria—Boston Scientific Corporation; Speaker’s Bureau—GlaxoSmithKline.

Sanjay Dixit, MD discloses the following, relevant to this program: Grant/Research Support—Boston Scientific Corporation; Consultant/Honoraria—BioSense Webster, Inc., Boston Scientific Corporation, and St. Jude Medical, Inc.

Igor D. Gregoric, MD does not have any discloses relevant to this program.

Douglas L. Mann, MD discloses the following, relevant to this program: Grant/Research Support—National Institutes of Health; Consultant/Honoraria—Acorn Cardiovascular, Inc. and Medtronic, Inc.; Scientific Advisory Board—ARMGO Pharma, Inc., Lpath, Inc., Nile Pharmaceuticals, and Cardiokine, Inc.

Emerson C. Perin, MD, PhD discloses the following, relevant to this program: Consultant/Honoraria—Cordis Corporation. In addition, he will discuss unlabeled or investigational uses of products.

In addition, peer reviewer, Patrick J. Hogan, MD has nothing to disclose relevant to this program.

 

Course Materials and CME Credit

This enduring material comprises 10 presentations. By clicking on the course materials link below, you acknowledge that you have reviewed the CME information provided above. After viewing all presentations, you must complete an assessment and evaluation to obtain CME credit for this activity.

Course Materials- Future Direction of Stem Cells


Return to Explore Archived Symposia.
 
Find Us on Facebook!

Please contact our Webmaster with questions or comments.
Terms of Use and Privacy Policy
© Copyright Texas Heart Institute. All rights reserved.
Texas Heart Institute, Texas Heart, Texas Heart Institute Journal, THI, Heart Owner's, Leading With the Heart and Heart of Discovery are members of the
family of trademarks of the Texas Heart Institute.


U.S. NEWS America's Best Hospitals 2012-13